Published in Urology on August 01, 2010
Immunohistochemical expression of ARID1A in penile squamous cell carcinomas: a tissue microarray study of 112 cases. Hum Pathol (2015) 0.78
Epigenetic mechanisms in penile carcinoma. Int J Mol Sci (2013) 0.77
Clinicopathologic and outcome features of superficial high-grade and deep low-grade squamous cell carcinomas of the penis. Springerplus (2015) 0.75
Extensive Presentation of Penile Carcinoma Cuniculatum a Variant of Squamous Cell Carcinoma With Low Malignant Potential. Urol Case Rep (2016) 0.75
Intraglomerular micrometastasis of squamous cell carcinoma. Clin Kidney J (2012) 0.75
Local Excision for the Treatment of Penile Verrucous Carcinoma. Urol Case Rep (2017) 0.75
Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology (2005) 3.40
Major response to imatinib mesylate in KIT-mutated melanoma. J Clin Oncol (2008) 3.16
Perineural invasion in cancer: a review of the literature. Cancer (2009) 3.06
Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol (2009) 3.04
EAU penile cancer guidelines 2009. Eur Urol (2010) 3.03
Cytological punctures in the diagnosis of renal tumours: a study on accuracy and reproducibility. Eur Urol (2008) 2.80
Characterization of TMPRSS2-ERG fusion high-grade prostatic intraepithelial neoplasia and potential clinical implications. Clin Cancer Res (2008) 2.58
Global gene expression analysis of reactive stroma in prostate cancer. Clin Cancer Res (2009) 2.34
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. Eur Urol (2007) 2.21
Core biopsies of renal tumors: a study on diagnostic accuracy, interobserver, and intraobserver variability. Eur Urol (2007) 2.15
Role of SRC-1 in the promotion of prostate cancer cell growth and tumor progression. Cancer Res (2005) 2.14
COUP-TFII inhibits TGF-β-induced growth barrier to promote prostate tumorigenesis. Nature (2012) 2.11
SRC-3 is required for prostate cancer cell proliferation and survival. Cancer Res (2005) 2.07
The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol (2013) 2.05
Molecular lymph node staging in bladder urothelial carcinoma: impact on survival. Eur Urol (2008) 2.04
EAU guidelines on testicular cancer: 2011 update. Eur Urol (2011) 1.96
Metastatic tumors to the penis: a report of 17 cases and review of the literature. Int J Surg Pathol (2010) 1.93
Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival. Clin Cancer Res (2002) 1.89
CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS. Nat Clin Pract Oncol (2008) 1.70
Multilocular cystic renal cell carcinoma : a report of 45 cases of a kidney tumor of low malignant potential. Am J Clin Pathol (2006) 1.69
High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy. Am J Surg Pathol (2004) 1.61
Steroid receptor coactivator-3/AIB1 promotes cell migration and invasiveness through focal adhesion turnover and matrix metalloproteinase expression. Cancer Res (2008) 1.54
Intraoperative consultation for renal lesions. Implications and diagnostic pitfalls in 324 cases. Am J Clin Pathol (2003) 1.52
The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer. Cancer Res (2004) 1.51
Pseudoglandular (adenoid, acantholytic) penile squamous cell carcinoma: a clinicopathologic and outcome study of 7 patients. Am J Surg Pathol (2009) 1.51
Recurrence at three months and high-grade recurrence as prognostic factor of progression in multivariate analysis of T1G2 bladder tumors. Urology (2009) 1.47
Comparative genomic hybridization analysis reveals new different subgroups in early-stage bladder tumors. Urology (2009) 1.44
What does the urologist expect from the pathologist (and what can the pathologists give) in reporting on adult kidney tumour specimens? Eur Urol (2006) 1.42
Establishment of antitumor memory in humans using in vitro-educated CD8+ T cells. Sci Transl Med (2011) 1.37
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II. Eur Urol (2007) 1.37
Human insulin analog--induced lipoatrophy. Diabetes Care (2007) 1.34
Relaxin promotes prostate cancer progression. Clin Cancer Res (2007) 1.34
Guidelines on testicular cancer. Eur Urol (2005) 1.32
Decreased expression and androgen regulation of the tumor suppressor gene INPP4B in prostate cancer. Cancer Res (2011) 1.32
Targeting Aurora kinases for the treatment of prostate cancer. Cancer Res (2006) 1.31
The role of inflammation and infection in the pathogenesis of prostate carcinoma. BJU Int (2007) 1.30
Pim-2 upregulation: biological implications associated with disease progression and perinueral invasion in prostate cancer. Prostate (2005) 1.24
Expression of the embryonic stem cell transcription factor SOX2 in human skin: relevance to melanocyte and merkel cell biology. Am J Pathol (2009) 1.22
Development of an immunoassay for serum caveolin-1: a novel biomarker for prostate cancer. Clin Cancer Res (2003) 1.22
Sarcomatoid carcinoma of the penis: a clinicopathologic study of 15 cases. Am J Surg Pathol (2005) 1.19
Activation of NF-{kappa}B by TMPRSS2/ERG Fusion Isoforms through Toll-Like Receptor-4. Cancer Res (2010) 1.18
Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohort. Clin Cancer Res (2006) 1.16
Utility of fluorescence in situ hybridization as a non-invasive technique in the diagnosis of upper urinary tract urothelial carcinoma. Eur Urol (2006) 1.14
Histopathologic spectrum of psoriasiform skin reactions associated with tumor necrosis factor-α inhibitor therapy. A study of 16 biopsies. Am J Dermatopathol (2010) 1.13
A second-look TUR in T1 transitional cell carcinoma: why? Eur Urol (2004) 1.13
Advances in the pathology of penile carcinomas. Hum Pathol (2012) 1.12
Penile squamous cell carcinoma clinicopathological features, nodal metastasis and outcome in 333 cases. J Urol (2009) 1.12
Expression of neutral amino acid transporter ASCT2 in human prostate. Anticancer Res (2003) 1.09
Standardization of Gleason grading among 337 European pathologists. Histopathology (2013) 1.09
FGFR-4 Arg³⁸⁸ enhances prostate cancer progression via extracellular signal-related kinase and serum response factor signaling. Clin Cancer Res (2011) 1.07
Carcinoma cuniculatum: a distinctive variant of penile squamous cell carcinoma: report of 7 cases. Am J Surg Pathol (2007) 1.05
GGAP2/PIKE-a directly activates both the Akt and nuclear factor-kappaB pathways and promotes prostate cancer progression. Cancer Res (2009) 1.04
Expression of vascular endothelial growth factor receptor-3 (VEGFR-3) in human prostate. Prostate (2004) 1.02
Conservative surgical therapy for leydig cell tumor. J Urol (2007) 1.02
Renal cystic neoplasms and renal neoplasms associated with cystic renal diseases: pathogenetic and molecular links. Adv Anat Pathol (2003) 1.01
The basaloid cell is the best tissue marker for human papillomavirus in invasive penile squamous cell carcinoma: a study of 202 cases from Paraguay. Am J Surg Pathol (2010) 1.01
Neuroepithelial interactions in prostate cancer are enhanced in the presence ofprostatic stroma. Urology (2003) 1.00
The reasons behind variation in Gleason grading of prostatic biopsies: areas of agreement and misconception among 266 European pathologists. Histopathology (2013) 0.99
Flexor carpi ulnaris tendinopathy. J Hand Surg Am (2005) 0.97
The role of human papillomavirus infection in the pathogenesis of penile squamous cell carcinomas. Semin Diagn Pathol (2012) 0.96
Psoriatic alopecia/alopecia areata-like reactions secondary to anti-tumor necrosis factor-α therapy: a novel cause of noncicatricial alopecia. Am J Dermatopathol (2011) 0.96
Prostate carcinoma II: prognostic factors in prostate needle biopsies. BJU Int (2006) 0.94
Epidemiologic profile, sexual history, pathologic features, and human papillomavirus status of 103 patients with penile carcinoma. World J Urol (2011) 0.94
Urothelial carcinoma of the bladder, lipid cell variant: clinicopathologic findings and LOH analysis. Am J Surg Pathol (2010) 0.93
The WHO/ISUP 1998 and WHO 1999 systems for malignancy grading of bladder cancer. Scientific foundation and translation to one another and previous systems. Virchows Arch (2002) 0.92
Lichen sclerosus in 68 patients with squamous cell carcinoma of the penis: frequent atypias and correlation with special carcinoma variants suggests a precancerous role. Am J Surg Pathol (2003) 0.92
Comparison of morphologic features and outcome of resected recurrent and nonrecurrent squamous cell carcinoma of the penis: a study of 81 cases. Am J Surg Pathol (2009) 0.91
Neural cell adhesion molecule is upregulated in nerves with prostate cancer invasion. Hum Pathol (2003) 0.90
The case for conservative management in the treatment of patients with non-muscle-invasive micropapillary bladder carcinoma without carcinoma in situ. Can J Urol (2010) 0.90
KISS1 methylation and expression as tumor stratification biomarkers and clinical outcome prognosticators for bladder cancer patients. Am J Pathol (2011) 0.89
Haploinsufficiency of the maspin tumor suppressor gene leads to hyperplastic lesions in prostate. Cancer Res (2008) 0.89
The prognostic index: a useful pathologic guide for prediction of nodal metastases and survival in penile squamous cell carcinoma. Am J Surg Pathol (2009) 0.89
Utility of a multiprobe fluorescence in situ hybridization assay in the detection of superficial urothelial bladder cancer. Cancer Genet Cytogenet (2007) 0.89
Utility of whole slide imaging and virtual microscopy in prostate pathology. APMIS (2012) 0.88
Interactive digital slides with heat maps: a novel method to improve the reproducibility of Gleason grading. Virchows Arch (2011) 0.88
Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data. Int J Radiat Oncol Biol Phys (2004) 0.88
Unclassified renal cell carcinoma: a report of 56 cases. BJU Int (2012) 0.88
Identification of PMF1 methylation in association with bladder cancer progression. Clin Cancer Res (2008) 0.88
Distinctive association of p16INK4a overexpression with penile intraepithelial neoplasia depicting warty and/or basaloid features: a study of 141 cases evaluating a new nomenclature. Am J Surg Pathol (2010) 0.88
Ethnic and racial differences in prostate stromal estrogen receptor alpha. Prostate (2005) 0.88
Penile squamous cell carcinoma: anatomic, pathologic and viral studies in Paraguay (1993-2007). Anal Quant Cytol Histol (2007) 0.87
Preputial variability and preferential association of long phimotic foreskins with penile cancer: an anatomic comparative study of types of foreskin in a general population and cancer patients. Am J Surg Pathol (2003) 0.87
Aluminum granuloma after administration of the quadrivalent human papillomavirus vaccine. Report of a case. Am J Dermatopathol (2008) 0.87
Histologic grade and perineural invasion are more important than tumor thickness as predictor of nodal metastasis in penile squamous cell carcinoma invading 5 to 10 mm. Am J Surg Pathol (2008) 0.87
Immunity to the melanoma inhibitor of apoptosis protein (ML-IAP; livin) in patients with malignant melanoma. Cancer Immunol Immunother (2011) 0.86
Limitations in the interpretation of biopsies in patients with penile squamous cell carcinoma. Int J Surg Pathol (2004) 0.86
Histologic grade in penile squamous cell carcinoma: visual estimation versus digital measurement of proportions of grades, adverse prognosis with any proportion of grade 3 and correlation of a Gleason-like system with nodal metastasis. Am J Surg Pathol (2009) 0.86
Autopsy findings in 14 patients with penile squamous cell carcinoma. Int J Surg Pathol (2009) 0.85